ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.32
+0.16 (1.75%)
At close: Jun 6, 2025, 4:00 PM
9.16
-0.16 (-1.72%)
After-hours: Jun 6, 2025, 4:30 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $662.54 million as of June 6, 2025. Its market cap has increased by 10.54% in one year.
Market Cap
662.54M
Enterprise Value
500.23M
1-Year Change
10.54%
Ranking
Category
Stock Price
$9.32
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has decreased from $741.98M to $662.54M, a decrease of -10.71%. That is a compound annual growth rate of -2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 662.54M | 16.34% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.38B |
| Johnson & Johnson | 369.72B |
| AbbVie | 331.15B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 268.37B |
| Abbott Laboratories | 233.03B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |